SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 362 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $35,000 | +6.1% | 467 | +9.1% | 0.00% | +100.0% |
Q1 2022 | $33,000 | -71.3% | 428 | -66.4% | 0.00% | -75.0% |
Q4 2021 | $115,000 | -20.7% | 1,273 | -18.9% | 0.00% | -33.3% |
Q3 2021 | $145,000 | -51.3% | 1,569 | -59.0% | 0.01% | -53.8% |
Q2 2021 | $298,000 | -23.4% | 3,831 | -26.5% | 0.01% | -35.0% |
Q1 2021 | $389,000 | -54.3% | 5,212 | +4.2% | 0.02% | -57.4% |
Q4 2020 | $852,000 | -14.0% | 5,004 | -29.1% | 0.05% | -26.6% |
Q3 2020 | $991,000 | +11.7% | 7,062 | +27.7% | 0.06% | -1.5% |
Q2 2020 | $887,000 | +210.1% | 5,529 | +89.1% | 0.06% | +170.8% |
Q1 2020 | $286,000 | -29.6% | 2,924 | -7.1% | 0.02% | -14.3% |
Q4 2019 | $406,000 | – | 3,149 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
IMS Capital Management | 32,215 | $774,000 | 0.91% |
Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |